Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis

被引:77
|
作者
Turlakow, A
Yeung, HWD
Pui, J
Macapinlac, H
Liebovitz, E
Rusch, V
Goy, A
Larson, SM
机构
[1] Mem Sloan Kettering Canc Ctr, Nucl Med Serv, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Hematol, New York, NY 10021 USA
[4] New York Presbyterian Hosp, Dept Rheumatol, New York, NY USA
关键词
D O I
10.1001/archinte.161.7.1003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe a case in which fludeoxyglucose F18 positron emission tomography (PET) led directly to the diagnosis of giant cell arteritis in an elderly woman with a fever of unknown origin. The patient presented with a 3-month history of fatigue, fever, headache, visual disturbance, jaw claudication, and anemia. A computed tomographic scan showed an anterior mediastinal mass that was suspected of being malignant. A fludeoxyglucose F 18 PET scan performed for preoperative evaluation identified striking uptake of fludeoxyglucose F 18 in the walls of the entire aorta, left main coronary artery, and sub-clavian, carotid, and common iliac arteries bilaterally, suggestive of an arteritis, a diagnosis subsequently confirmed by the findings of an arterial biopsy. Her erythrocyte sedimentation rate was 129 mm/h. There was normalizaton of the PET scan 2 weeks following treatment with prednisolone. This case suggests that fludeoxyglucose F 18 PET contributes to the noninvasive diagnosis of giant cell arteritis, as well as to the evaluation of the extent of disease, response to therapy, and disease recurrence.
引用
收藏
页码:1003 / 1007
页数:5
相关论文
共 50 条
  • [1] Positron emission tomography in the diagnosis of giant cell arteritis
    Fletcher, TM
    Espinola, D
    CLINICAL NUCLEAR MEDICINE, 2004, 29 (10) : 617 - 619
  • [2] Positron emission tomography in the diagnosis and management of giant cell arteritis
    Szmodis, Michael L.
    Reba, Richard C.
    Earl-Graef, David
    HEADACHE, 2007, 47 (08): : 1216 - 1219
  • [3] Reply: Fluorodeoxyglucose positron emission tomography for the diagnosis of giant cell arteritis
    Brodmann, M
    Pilger, E
    RHEUMATOLOGY, 2004, 43 (05) : 679 - 680
  • [4] EVALUATION OF BASELINE POSITRON EMISSION TOMOGRAPHY IN THE DIAGNOSIS AND ASSESSMENT OF GIANT CELL ARTERITIS
    Ince, B.
    Isik, E. G.
    Ozkan, Z. G.
    Yalcinkaya, Y.
    Artim-Esen, B.
    Gul, A.
    Ocal, M. L.
    Inanc, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1210 - 1211
  • [5] Fluorodeoxyglucose Positron Emission Tomography for Giant Cell Arteritis
    Blockmans, Daniel
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (12) : 1763 - 1764
  • [6] Potentialities of positron emission tomography in diagnosis and control of efficacy of giant cell arteritis treatment
    Gordeev, A., V
    Uskoya, Yu. A.
    Rudas, M. S.
    TERAPEVTICHESKII ARKHIV, 2008, 80 (10) : 93 - 94
  • [7] Positron Emission Tomography/Computed Tomography for the Diagnosis and Assessment of Giant Cell Arteritis: When to Consider It and Why
    Clifford, Alison
    Burrell, Steven
    Hanly, John G.
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (10) : 1909 - 1911
  • [8] Clinical Images: Giant cell arteritis revealed by positron emission tomography
    Loeb, JM
    Engelstad, B
    ARTHRITIS AND RHEUMATISM, 2006, 54 (05): : 1710 - 1710
  • [9] Positron emission tomography in giant cell arteritis: a new diagnostic tool?
    Novikov, P. I.
    Meshkov, A. D.
    Moiseev, S. V.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (11) : E70 - E70
  • [10] Clinical Images: Crowned dens syndrome detected on 18F-fludeoxyglucose-positron emission tomography/computed tomography during investigation for giant cell arteritis
    Lim, Miao Yunn
    Shon, Ivan Ho
    Sammel, Anthony M.
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 (04) : 664 - 665